News

August 2022 - Vincere Awarded Grant Funding From the Michael J. Fox Foundation

Boston, MA - June 2022: Vincere Biosciences Inc initiates new in vivo studies for Parkinson's disease with new funding from the Michael J. Fox...

Vincere Awarded Grant Funding From MJFF
9th Aging Research & Drug Discovery Meeting

August 2022 - Vincere Scientific Project Manager Sam Sharifi to present data at the 9th Aging Research & Drug Discovery Meeting

Copenhagan, Denmark - August 2022: Dr Sharifi was invited to present a poster sharing the longevity and healthspan potential of Vincere's USP30 inhibitor small molecules.

June 2022 - Vincere Awarded Grant Funding From National Institute of Aging

Boston, MA - June 2022: Vincere Biosciences Inc is expanding into cardiac and longevity indications with new funding from...

Vincere Awarded Grant Funding From NIA
Agile Falcon Strategic Group's 9th Drug Discovery Strategic Summit

May 2022 - Vincere COO Andy Lee to give keynote address at the 9th virtual Drug Discovery Strategic Summit

Boston, MA - May 2022: Andy Lee was invited to give a keynote address on application of systems biology in drug discovery.

March 2022 - Vincere CEO Spring Behrouz, Ph.D. presents at AD/PD 2022

Barcelona, Spain and online - March 2022: Dr. Spring Behrouz, Ph.D. will present a scientific update on Vincere's USP30 inhibitor program with a recorded virtual poster session.

AD/PD 2022
Agile Falcon Strategic Group's 7th Drug Discovery Strategic Summit

June 2021 - Vincere COO Andy Lee gave keynote address at the 7th virtual Drug Discovery Strategic Summit

Online - June 2021: Andy Lee was invited to give a keynote address on overcoming the lack of evidence for finding new drug candidates in drug discovery.

April 2021 - Vincere CEO Spring Behrouz, Ph.D. Participates in Parkinson’s Disease Panel at Sachs 4th Annual Neuroscience Innovation Forum (NIF)

Online - April 2021: Dr. Spring Behrouz, Ph.D. was invited to speak in the Parkinson’s and Movement Disorders Panel during a live session on Therapeutics Day 2 on April 28 as part of the SACHS Associates' 4th Annual Neuroscience Innovation Forum (NIF). Vincere Biosciences was also featured during the conference’s Company Showcase for Business Development, Licensing & Investment from April 28 to April 30.

Sachs Associates 4th annual Neuroscience innovation forum
Bristol Myers Squibb and Lab Central

November 2020 - Vincere Biosciences awarded the Lab Central Golden Ticket by Bristol Myers Squibb

Cambridge - November 2020: Vincere Biosciences is pleased to be chosen as one of two winners of Bristol Myers Squibb’s 2020 Golden Tickets for LabCentral. The prize will cover the cost of one lab bench and one resident scientist fee at LabCentral’s Kendall Square facility for one year.

September 2020 - Vincere Biosciences selected as a top 10 finalist from 1300 applications for the Entrepreneurship World Cup 2020 - US East Coast Division

Online - September 2020: Dr. Spring Behrouz, Ph.D. represented Vincere Biosciences to pitch during the Entrepreneurship World Cup 2020, East Coast Semi-finals. Entrepreneurship World Cup is the world’s largest entrepreneurship ecosystem, with 199 participating countries, more than 150,000 entrepreneurs, and an annual competition to showcase the world’s most innovative startups.

Vincere Entrepreneurship World Cup 2020 US East Coast Finals
Awardee, JLABS Pitch Competition 2020

September 2020 - Vincere CEO Spring Behrouz, Ph.D. participates in Johnson & Johnson Innovation | JLABS pitch competition

Online - September 2020: Vincere Biosciences is slated to present alongside five other semifinalists during a pitch competition and investor panel hosted by JLABS.

September 2020 - Vincere COO Andy Lee presents at the 2020 Biopharm America Conference

Online - September 2020: Online - September 2020: Andy Lee will present a case study on Drug Discovery Models to Prioritize Pathways and Targets for Parkinson’s Disease during the AI Applications for Drug Discovery & Development Conference as part of the 13th annual Biopharm America and Biotech Week Boston.

AI Applications for Drug Discovery and Development - part of BIOPHARM AMERICA
Johnson & Johnson JLABS logo

July 2020 - Vincere CEO Spring Behrouz, PhD presents at Johnson & Johnson Innovation | JLABS webinar on Parkinson’s Disease research

Online - July 2020: Dr. Spring Behrouz Ph.D. presents alongside 3 leading researchers in the Parkinson Disease field on July 28 in a webinar titled, “Parkinson’s Disease: Genetics, Disease Mechanisms and Novel Therapeutic Targets.” The speakers will discuss new insights gleaned from the latest research in PD genetics, disease biology, and applications of the identification of PD-associated genes to drug discovery.

April 2020 - Vincere Biosciences Receives Funding from the National Institutes of Health

Cambridge, MA, USA - April 2020: Vincere Biosciences, Inc has been awarded a Phase I SBIR grant from the National Institute of Neurological Disorders and Stroke to develop inhibitors of USP30...

NIH, NILDS, and Vincere logos
Keystone Symposia flier

February 2020 - Vincere CSO Kalpana Merchant, PhD organized and presented at Keystone Symposia

Santa Fe, NM - February 2020: Kalpana Merchant, Ph.D. gave a talk on technologies that de-risk and enable CNS drug discovery and development, in which she exemplified systems biology combined with NeuroInitiative's computational technology for target ID/validation and discussed the importance of engineering and validating flow scheme assays to garner confidence in the hits using the parkin activator program.

January 2020 - Vincere CEO Spring Behrouz, PhD presents at Biotech Showcase.

San Francisco, CA - January 2020: Spring Behrouz, PhD selected to present in the Seed Showcase during JPM on Wednesday January 15, 2020.

JPM Digital Medicine & Medtech Showcase flier
3rd Annual Neuroscience Innovation Forum flier

January 2020 - Vincere CEO Spring Behrouz, PhD presents at the Neuroscience Innovation Forum.

San Francisco, CA - January 2020: Spring Behrouz, PhD will present an introduction and data on Vincere's emerging small-molecule program targeting mitochondrial homeostasis during JPM on Sunday January 12, 2020.

December 2019 - Vincere COO Andy Lee presents at the BioData World Congress 2019.

Basel, Switzerland - December 2019: Andy Lee will present on Bridging the Gap Between Biology and Technology, sharing how Vincere has implemented unique computational tools and cross-functional teams to accelerate drug discovery.

BioData World Congress 2019 flier
Xconomy Con 2019 flier

October 2019 - Vincere CEO Spring Behrouz, PhD presents at X-Con 2019.

Lincoln, MA - October 2019: Spring Behrouz, PhD will discuss "Biopharma's AI Scouts" on a panel moderated by Xconomy Editor in Chief Greg Huang.

September 2019 - Vincere CEO Spring Behrouz, PhD presents at the 2019 Biopharm America Conference.

Boston, MA - September 2019: Spring Behrouz, PhD will present an introduction and data on Vincere's emerging small-molecule program targeting mitochondrial homeostasis in room 252A at 1:30PM on September 11, 2019.

12th Annual Biopharm America 2019 flier
Pictures of Dario Alessi, Stephen K. Burley, and Peter Lansbury above the Vincere logo

July 2019 - Vincere Biosciences Welcomes Dario Alessi, Stephen K. Burley, and Peter Lansbury to Scientific Advisory Board

Cambridge, MA, USA - July 2019: Vincere Biosciences, Inc welcomes Dario Alessi, PhD, Stephen K. Burley, MD, DPhil, and Peter Lansbury, PhD to its Scientific Advisory Board...

June 2019 - Vincere CSO Kalpana Merchant, PhD presents at the 2019 World Parkinson's Congress.

Kyoto, Japan - June 2019: Kalpana Merchant, PhD will chair multiple panels and present on the process of taking a therapy from the lab, to the clinic, to the market.

5th World Parkinson Congress Kyoto 2019 flier
Michael J. Fox Foundation for Parkinson's Research logo

May 2019 - Vincere Biosciences Receives Funding from the Michael J. Fox Foundation

Cambridge, MA, USA - May 2019: Vincere Biosciences, Inc has received a grant from the Michael J Fox Foundation to accelerate the development of small molecule activators...

May 2019 - Vincere CEO Spring Behrouz, PhD presents at the 2019 Neuro4D conference.

Mainz, Germany - May 2019: Spring Behrouz, PhD will present the suite of computational drug discovery tools used by Vincere.

Neuro 4D - Degenerative Disease Drug Discovery
Society for Neuroscience presentation 628.04

November 2018 - Vincere Senior Scientist Jason Hall, PhD presents at the 2018 Society for Neuroscience conference.

San Diego, CA - November 2018: Jason Hall, PhD will present a nansymposium talk entitled "In silico simulation of parkin cellular pathways: Elucidating mechanisms of Parkinson’s disease"

November 2018 - Vincere COO Andy Lee presents at the 2018 Society for Neuroscience conference.

San Diego, CA - November 2018: Andy Lee will present a dynamic poster entitled "Converging pathways in genetic and sporadic Parkinson’s disease: Using unbiased network analysis to connect the dots"

Neuroscience 2018 flier
Vincere - Invent The Future

October 2018 - Vincere Biosciences Inc launches to win the fight against Parkinson’s disease

Cambridge, MA, USA - October 2018: Vincere Biosciences, Inc, a Delaware corporation headquartered in Cambridge, MA was created to commercialize a series of therapeutic assets...